Perrigo | PRGO - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
AbbVie USD -5.94B 721M 2026-06
Abbott USD 52.06B 69M 2026-03
Bayer EUR 29.71B 863M 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Coherus Biosciences USD 60.84M 17.78M 2026-06
Corcept Therapeutics USD 705.78M 67.79M 2026-06
Dr.Reddys Laboratories INR 386.74B 7.82B 2026-06
Eli Lilly USD 33.88B 2.68B 2026-06
J&J USD 84.97B 3.78B 2026-06
Merck USD 41.93B 3.94B 2026-06
Nestle CHF 29.23B 3.58B 2026-06
Pacira USD 671.98M 18.08M 2026-06
Perrigo USD 2.52B 17M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 1.92B 29.2M 2026-06
Reckitt Benckiser GBP 6.7B 1.39B 2024-12
Sanofi EUR 69.57B 3.24B 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
Teva Pharmaceutical Industries USD 7.75B 475M 2026-06
Xeris Pharmaceuticals USD -9.73M 22.74M 2026-06
Zoetis USD 3.15B 85M 2026-06